Accession Number: | 0001209191-20-005356 |
Date: | 2020-01-28 |
Issuer: | VERISK ANALYTICS, INC. (VRSK) |
Original Submission Date: |
THOMPSON KENNETH E
C/O VERISK ANALYTICS, INC.
545 WASHINGTON BOULEVARD
JERSEY CITY, NJ 07310
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-28 | M | 20,254 | a | $28.20 | 66,546 | direct | ||
COMMON STOCK | 2020-01-28 | S | 20,254 | d | $165.16 | 46,292 | direct | ||
COMMON STOCK | 2020-01-29 | M | 1,469 | a | $28.20 | 47,761 | direct | ||
COMMON STOCK | 2020-01-29 | S | 1,469 | d | $165.00 | 46,292 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 28.2 | 2020-01-28 | deemed execution date | M | 20,254 (d) | 2020-04-01 | common stock 20,254 | $28.20 | 1,469 | direct | ||
STOCK OPTION | 28.2 | 2020-01-29 | deemed execution date | M | 1,469 (d) | 2020-04-01 | common stock 1,469 | $28.20 | 0 | direct |
ID | footnote |
---|---|
f1 | these shares were sold pursuant to a 10b5-1 plan. this sale price is a weighted average sale price that represents the sale of these shares of common stock at prices ranging from $165.00 to $165.48, inclusive. the reporting person undertakes to provide upon request by the sec staff, the issuer or any security holder of the issuer, full information regarding the number of shares of common stock sold at each separate price within the ranges set forth in this footnote (1). |
f2 | these shares were sold pursuant to a 10b5-1 plan. |
f3 | stock options outstanding under the issuer's 2009 equity incentive plan. |
f4 | immediately. |